Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1977 Oct;36(5):433–441. doi: 10.1136/ard.36.5.433

Cellular immunity in systemic lupus erythematosus as evidenced in vitro by leucocyte migration inhibition tests.

M Okubo, Y Nagura, D Pompa, G Treser, K Lange
PMCID: PMC1000135  PMID: 921343

Abstract

A leucocyte migration inhibition test was performed on 26 patients with systemic lupus erythematosus (SLE) and on 35 control subjects using three different antigens, fetal calf thymus DNA, baker's yeast RNA, and calf thymus extractable nuclear antigen (ENA). Leucocyte migration was inhibited by DNA in 17 out of 26 SLE patients (65-3%), and in only 2 of the 35 controls (5-7%). When RNA or ENA was added none of the patients or controls showed inhibition. In SLE patients migration inhibition by DNA was significantly correlated with the presence of proteinuria and/or granular casts in urinary sediment. When the migration inhibition test was positive, immunofluorescence verified active histology of the glomeruli obtained by a percutaneous renal biopsy.

Full text

PDF
433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe T., Hara M., Yamasaki K., Homma M. Cell-mediated immune response in systemic lupus erythematosus. In vitro cellular response to native DNA by macrophage inhibitory test. Arthritis Rheum. 1973 Sep-Oct;16(5):688–694. doi: 10.1002/art.1780160514. [DOI] [PubMed] [Google Scholar]
  2. Asano S., Marumo K., Igaki Y., Toyoizumi E., Okubo M. Serum complement in systemic lupus erythematosus (SLE). Arerugi. 1968 Jul;17(7):597–609. [PubMed] [Google Scholar]
  3. DEICHER H. R., HOLMAN H. R., KUNKEL H. G. The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus. J Exp Med. 1959 Jan 1;109(1):97–114. doi: 10.1084/jem.109.1.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dormont J., Sobel A., Galanaud P., Boelaert J., Mery J. P., Richet G. Exploration de l'immunité cellulaire au cours du lupus érythémateux disséminé. J Urol Nephrol (Paris) 1972 Dec;78(12):980–987. [PubMed] [Google Scholar]
  5. Federlin K., Helmke K. Depression of cellular hypersensitivity to D.N.A. in systemic lupus erythematosus. Lancet. 1972 Mar 11;1(7750):596–597. doi: 10.1016/s0140-6736(72)90393-5. [DOI] [PubMed] [Google Scholar]
  6. Galanaud P., Dormont J., Crosnier J., Mery J. P. Leucocyte-migration test in seronegative S.L.E. Lancet. 1971 Oct 23;2(7730):923–923. doi: 10.1016/s0140-6736(71)92528-1. [DOI] [PubMed] [Google Scholar]
  7. Goldman J. A., Litwin A., Adams L. E., Krueger R. C., Hess E. V. Cellular immunity to nuclear antigens in systemic lupus erythematosus. J Clin Invest. 1972 Oct;51(10):2669–2677. doi: 10.1172/JCI107085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HOLMAN H. R., DEICHER H. R., KUNKEL H. G. The L. E. cell and the L. E. serum factors. Bull N Y Acad Med. 1959 Jul;35(7):409–418. [PMC free article] [PubMed] [Google Scholar]
  9. Hahn B. H., Bagby K. K., Osterland C. K. Abnormalities of delayed hypersensitivity in systemic lupus erythematosus. Am J Med. 1973 Jul;55(1):25–31. doi: 10.1016/0002-9343(73)90146-0. [DOI] [PubMed] [Google Scholar]
  10. Hahn B. H., Bagby M. K., Osterland C. K. Disparity between humoral and cellular immune responses to desoxyribonucleic acid in systemic lupus erythematosus. Am J Med Sci. 1973 Sep;266(3):193–201. doi: 10.1097/00000441-197309000-00005. [DOI] [PubMed] [Google Scholar]
  11. Harbeck R. J., Bardana E. J., Kohler P. F., Carr R. I. DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera. J Clin Invest. 1973 Apr;52(4):789–795. doi: 10.1172/JCI107242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Horwitz D. A. Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum. 1972 Jul-Aug;15(4):353–359. doi: 10.1002/art.1780150406. [DOI] [PubMed] [Google Scholar]
  13. Hughes G. R. Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet. 1971 Oct 16;2(7729):861–863. doi: 10.1016/s0140-6736(71)90234-0. [DOI] [PubMed] [Google Scholar]
  14. Kaltreider H. B., Soghor D., Taylor J. B., Decker J. L. Capillary tube migration for detection of human delayed hypersensitivity: difficulties encountered with "buffy coat" cells and tuberculin antigen. J Immunol. 1969 Aug;103(2):179–184. [PubMed] [Google Scholar]
  15. Koffler D., Schur P. H., Kunkel H. G. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967 Oct 1;126(4):607–624. doi: 10.1084/jem.126.4.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. LANGE K., WASSERMAN E., SLOBODY L. B. The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus. Ann Intern Med. 1960 Oct;53:636–646. doi: 10.7326/0003-4819-53-4-636. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Lange K., Treser G., Sagel I., Ty A., Wasserman E. Routine immunohistology in renal diseases. Ann Intern Med. 1966 Jan;64(1):25–40. doi: 10.7326/0003-4819-64-1-25. [DOI] [PubMed] [Google Scholar]
  19. Lockshin M. D. Failure to demonstrate leukocyte migration inhibition in human tuberculin hypersensitivity. Proc Soc Exp Biol Med. 1969 Dec;132(3):928–930. doi: 10.3181/00379727-132-34339. [DOI] [PubMed] [Google Scholar]
  20. McCluskey R. T., Vassalli P., Gallo G., Baldwin D. S. An immunofluorescent study of pathogenic mechanisms in glomerular diseases. N Engl J Med. 1966 Mar 31;274(13):695–701. doi: 10.1056/NEJM196603312741301. [DOI] [PubMed] [Google Scholar]
  21. Messner R. P., Lindström F. D., Williams R. C., Jr Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest. 1973 Dec;52(12):3046–3056. doi: 10.1172/JCI107503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Moulias R., Goust J. M., Reinert P., Devillechabrolle A., Muller Berat C. N., Hereman C., Godeau P. Le test de migration en présence d'ADN des leucocytes au cours du lupus érythémateux disséminé. Nouv Presse Med. 1972 May 20;1(21):1403–1407. [PubMed] [Google Scholar]
  23. ORES R. O., LANGE K. SKIN TEST FOR THE DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS. Am J Med Sci. 1964 Nov;248:562–566. doi: 10.1097/00000441-196411000-00007. [DOI] [PubMed] [Google Scholar]
  24. Okubo M. [In vitro response of peripheral lymphocytes from patients with systemic lupus erythematosus to DNA]. Nihon Naika Gakkai Zasshi. 1968 Jul;57(7):758–770. doi: 10.2169/naika.57.758. [DOI] [PubMed] [Google Scholar]
  25. Patrucco A., Rothfield N. F., Hirschhorn K. The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA. Arthritis Rheum. 1967 Feb;10(1):32–37. doi: 10.1002/art.1780100105. [DOI] [PubMed] [Google Scholar]
  26. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  27. Podleski W. K., Podleski U. G. Circulating sensitized lymphocytes in systemic lupus erythematosus. Nature. 1973 Jan 26;241(5387):278–279. doi: 10.1038/241278a0. [DOI] [PubMed] [Google Scholar]
  28. RIGGS J. L., LOH P. C., EVELAND W. C. A simple fractionation method for preparation of fluorescein-labeled gamma globulin. Proc Soc Exp Biol Med. 1960 Dec;105:655–658. doi: 10.3181/00379727-105-26207. [DOI] [PubMed] [Google Scholar]
  29. Reinert P., Devillechabrolle A., Bribet-Forette F., Chigot D., Moulias R. Le test de transformation blastique des lymphocytes (T.T.L.) appliqué au diagnostic des affections auto-immunes. Premiers résultats en présence d'antigènes thyroïkiens et d'AD. Presse Med. 1971 Jun 5;79(28):1279–1281. [PubMed] [Google Scholar]
  30. STOLLAR D., LEVINE L., MARMUR J. Antibodies to enatured deoxyribonucleic acid in lupus erythematosus serum. II. Characterization of antibodies in several sera. Biochim Biophys Acta. 1962 Jul 9;61:7–18. doi: 10.1016/0926-6550(62)90023-3. [DOI] [PubMed] [Google Scholar]
  31. Sharp G. C., Irvin W. S., LaRoque R. L., Velez C., Daly V., Kaiser A. D., Holman H. R. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest. 1971 Feb;50(2):350–359. doi: 10.1172/JCI106502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972 Feb;52(2):148–159. doi: 10.1016/0002-9343(72)90064-2. [DOI] [PubMed] [Google Scholar]
  33. Soborg M., Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand. 1967 Feb;181(2):247–256. doi: 10.1111/j.0954-6820.1967.tb07255.x. [DOI] [PubMed] [Google Scholar]
  34. Soborg M. In vitro detection of cellular hypersensitivity in man. Specific migration inhibition of white blood cells from brucella-positive persons. Acta Med Scand. 1967 Aug;182(2):167–174. [PubMed] [Google Scholar]
  35. Tan E. M., Schur P. H., Carr R. I., Kunkel H. G. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1966 Nov;45(11):1732–1740. doi: 10.1172/JCI105479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Williams R. C., Jr, DeBoard J. R., Mellbye O. J., Messner R. P., Lindström F. D. Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest. 1973 Feb;52(2):283–295. doi: 10.1172/JCI107184. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES